Ubiquiti Inc. Interest Paid decreased by 87.1% to $211.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 96.6%, from $6.18M to $211.00K. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 27.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.36M | $2.50M | $2.32M | $2.59M | $4.16M | $6.74M | $11.74M | $15.76M | $19.63M | $21.69M | $19.41M | $18.49M | $15.51M | $12.02M | $8.26M | $6.18M | $4.59M | $3.23M | $1.64M | $211.00K |
| QoQ Change | — | +6.1% | -7.4% | +11.7% | +60.7% | +62.0% | +74.3% | +34.2% | +24.6% | +10.5% | -10.5% | -4.7% | -16.1% | -22.5% | -31.3% | -25.2% | -25.7% | -29.6% | -49.3% | -87.1% |
| YoY Change | — | — | — | — | +76.3% | +169.4% | +407.3% | +509.2% | +372.1% | +221.9% | +65.3% | +17.3% | -21.0% | -44.6% | -57.5% | -66.6% | -70.4% | -73.1% | -80.2% | -96.6% |